Vol 72, No 4 (2021)
Clinical vignette
Published online: 2021-05-17

open access

Page views 1079
Article views/downloads 447
Get Citation

Connect on Social Media

Connect on Social Media

A rare case of aggressive, hereditary paraganglioma associated with a pathogenic variant in SDHD

Anna Kurzyńska1, Elwira Przybylik-Mazurek1, Anna Skalniak1, Monika Buziak-Bereza1, Agata Brzozowska-Czarnek2, Romana Tomaszewska3, Alicja Hubalewska-Dydejczyk1
Pubmed: 34010450
Endokrynol Pol 2021;72(4):403-403.


Not required for Clinical Vignette.

Article available in PDF format

View PDF Download PDF file


  1. Buffet A, Burnichon N, Favier J, et al. An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma. Best Pract Res Clin Endocrinol Metab. 2020; 34(2): 101416.
  2. Hensen EF, Jordanova ES, van Minderhout IJ, et al. Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families. Oncogene. 2004; 23(23): 4076–4083.
  3. Tufton N, Sahdev A, Drake WM, et al. Can subunit-specific phenotypes guide surveillance imaging decisions in asymptomatic SDH mutation carriers? Clin Endocrinol (Oxf). 2019; 90(1): 31–46.
  4. Koopman K, Gaal J, de Krijger RR. Pheochromocytomas and Paragangliomas: New Developments with Regard to Classification, Genetics, and Cell of Origin. Cancers (Basel). 2019; 11(8).
  5. Lee H, Jeong S, Yu Y, et al. Risk of metastatic pheochromocytoma and paraganglioma in mutation carriers: a systematic review and updated meta-analysis. J Med Genet. 2020; 57(4): 217–225.